The effect of H 2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines

Digestive Diseases and Sciences

Volumn 49, Issue 10, 2004, Pages 1634-1640

  Rajendra, Shanmugarajah ^a   Mulcahy, Hugh ^a   Patchett, Stephen ^a   Kumar, Parveen ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

apoptosis; colorectal cancer; H 2 antagonists; proliferation

Indexed keywords

ADENOSINE PHOSPHATE; CIMETIDINE; DNA FRAGMENT; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; RANITIDINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; ADENOCARCINOMA; CELL STRAIN CACO 2; COLORECTAL TUMOR; COLORIMETRY; DRUG COMBINATION; DRUG EFFECT; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; CACO-2 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; CIMETIDINE; COLORECTAL NEOPLASMS; COLORIMETRY; DRUG COMBINATIONS; HISTAMINE; HISTAMINE H2 ANTAGONISTS; HUMANS; RANITIDINE;

EID: 5044236772     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000043377.30075.ac     Document Type: Article

References (29)

1. Tonnesen H, Bulow S, Fischerman K, et al.: Effect of cimetidine on survival after gastric cancer. Lancet 2:990-992, 1988
2. Adams WJ, Morris DL, Ross WB, et al.: Cimetidine preserves non-specific immune function after colonie resection for cancer. Aust NZ J Surg 64(12):847-852, 1994
3. Matsumoto S: Cimetidine and survival with colorectal cancer. Lancet 346:115, 1995
4. Svendsen LB, Ross C, Knigge U, et al.: Cimetidine as an adjuvant treatment in colorectal cancer. Dis Col Rect 38(5):514-518, 1995
5. Nielsen HJ, Christensen IJ, Moesgaard F, Kehlet H: Danish RANX05 Colorectal Cancer Study Group. Ranitidine as adjuvant treatment in colorectal cancer. Br J Surg 89:1416-1422, 2002
6. Garcia-Caballero M, Nunezed X, Castro I, Kusche J, Vora-Thorbeck L: Histamine metabolism in human breast and colorectal cancer: Its effect on other host tissues. Adv Biosci 89:273-287, 1993
7. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29, 1988
8. Watson SA, Wilkinson LJ, Robertson JFR, et al: Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 34:1091-1096, 1993
9. Adams WJ, Lawson JA, Morris DL: Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35:1632-1636, 1994
10. Kumar A: Cimetidine: An immunomodulator. Ann Pharmacother 24:289-295, 1990
11. Kimura E, Koike T, Shimizu Y, Kodama M: Complexes of the histamine H2-antagonist cimetidine with divalent and monovalent copper ions. Inorg Chem 25:2242-2246, 1986
12. Hansbrough JF, Zapata-Sirvent RL, Bender EM: Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg 151:249-255, 1986
13. Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y: Cimetidine and immunoreactivity. Lancet 348:404-405, 1996
14. Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T: Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60:3978-3984, 2000
15. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Okamoto T: Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis A epitope expression on tumour cells. Br J Cancer 86:161-167, 2002
16. Sasson AR, Gamagami R, An Z, Wang X, Moossa AR, Hoffman R: Cimetidine: An inhibitor or promoter of tumour growth? Int J Cancer 81:835-838, 1999
17. Lawson JA, Adams WJ, Morris DL: Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonie cancer growth. Br J Cancer 73:872-876, 1996
18. Cory AH, Owen TC, Barltop JA, et al: Use of a tetrazolium/ formazan assay for cell growth assays in culture. Cancer Commun 3(7):207-212, 1991
19. Volker TT, Viratelle OM, Delaage MA, et al.: Radioimmunoassay of cyclic AMP can provide a highly sensitive assay for adenylate cyclase, even at very high ATP concentrations. Anal Biochem 144(2):347-355, 1985
20. Burtin C, Scheinmann P, Salomon JC, et al.: Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H1 and H2 histamine receptors. Br J Cancer 45:54-60, 1982
21. Burtin C, Scheinmann P, Fray A, et al.: Ranitidine and cancer. N Engl J Med 310:1603, 1984
22. Beer DJ, Rocklin RE: Histamine modulation of lymphocyte biology: Membrane receptors, signal transduction and functions. Crit Rev Immunol 7:55-91, 1987
23. Gifford RRM, Gamble CE, Schmidtke JR, et al: Cimetidine augmentation of in vitro generated cell mediated cytotoxicity. Surg Forum 31:379-382, 1980
24. Gifford RRM, Vallera DA: Cimetidine induced augmentation of murine cell mediated cytotoxicity following in vitro and in vivo treatment. Fed Proc 39:924, 1980
25. Morris DL, Adams WJ: Cimetidine and colorectal cancer - Old drug, new use? Nature Med 1(12):1243-1244, 1995
26. Lawson J, Adams W, Morris D: Cimetidine but not ranitidine inhibits histamine stimulated growth of the human colonie cancer cell line C170. Aust NZ J Surg 64:361, 1994
27. Tutton PJ, Barkla DH: Comparison of the tumour inhibiting effects of three histamine receptor antagonists. Anticancer Res. 3:7-10, 1983
28. Soldatenkov VA, Danisenko MF, Khodarev NN, et al: Early postirradiation chromatin degradation in thymocytes. Int J Radiat Biol 55(6):943-951, 1989
29. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:257-306, 1980